Magnetar Financial LLC increased its position in Hill-Rom Holdings, Inc. (NYSE:HRC) by 24.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 17,458 shares of the medical technology company’s stock after buying an additional 3,421 shares during the period. Magnetar Financial LLC’s holdings in Hill-Rom were worth $1,292,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Seven Eight Capital LP acquired a new position in Hill-Rom in the second quarter worth approximately $127,000. Acrospire Investment Management LLC grew its holdings in Hill-Rom by 43.4% during the second quarter. Acrospire Investment Management LLC now owns 1,983 shares of the medical technology company’s stock valued at $158,000 after purchasing an additional 600 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Hill-Rom by 10.2% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,201 shares of the medical technology company’s stock valued at $175,000 after purchasing an additional 204 shares during the last quarter. Citigroup Inc. grew its holdings in Hill-Rom by 21.1% during the second quarter. Citigroup Inc. now owns 2,483 shares of the medical technology company’s stock valued at $198,000 after purchasing an additional 433 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale grew its holdings in Hill-Rom by 101.0% during the third quarter. DekaBank Deutsche Girozentrale now owns 2,720 shares of the medical technology company’s stock valued at $204,000 after purchasing an additional 1,367 shares during the last quarter. Hedge funds and other institutional investors own 82.35% of the company’s stock.
Several equities analysts have commented on HRC shares. KeyCorp reiterated a “buy” rating and set a $89.00 price target (up previously from $82.00) on shares of Hill-Rom in a report on Sunday, November 5th. Stifel Nicolaus reiterated a “buy” rating and set a $92.00 price target on shares of Hill-Rom in a report on Wednesday, November 29th. Zacks Investment Research upgraded Hill-Rom from a “hold” rating to a “buy” rating and set a $90.00 price target on the stock in a report on Friday, October 27th. Needham & Company LLC lowered their price target on Hill-Rom from $93.00 to $90.00 and set a “buy” rating on the stock in a report on Monday, November 6th. Finally, ValuEngine downgraded Hill-Rom from a “buy” rating to a “hold” rating in a report on Saturday, November 4th. Five investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $89.57.
Shares of Hill-Rom Holdings, Inc. (NYSE HRC) opened at $83.20 on Friday. Hill-Rom Holdings, Inc. has a 12-month low of $54.59 and a 12-month high of $85.25. The company has a debt-to-equity ratio of 1.55, a current ratio of 1.77 and a quick ratio of 1.34. The firm has a market capitalization of $5,492.10, a P/E ratio of 21.62, a PEG ratio of 1.77 and a beta of 1.19.
Hill-Rom (NYSE:HRC) last posted its quarterly earnings data on Friday, November 3rd. The medical technology company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.05. Hill-Rom had a return on equity of 20.27% and a net margin of 4.87%. The company had revenue of $738.30 million during the quarter, compared to analysts’ expectations of $731.10 million. During the same period in the prior year, the business earned $1.18 earnings per share. Hill-Rom’s revenue for the quarter was up 4.6% compared to the same quarter last year. sell-side analysts anticipate that Hill-Rom Holdings, Inc. will post 4.26 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, December 29th. Investors of record on Friday, December 15th will be given a $0.18 dividend. The ex-dividend date of this dividend is Thursday, December 14th. This represents a $0.72 annualized dividend and a yield of 0.87%. Hill-Rom’s dividend payout ratio (DPR) is currently 36.18%.
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.